CONTEXT: Current guidelines recommend parathyroidectomy in patients with primary hyperparathyroidism (PHPT) who have an estimated glomerular filtration rate (eGFR) less than 60 ml/min per 1.73 m(2). It is unclear, however, whether values below this threshold of renal impairment affect bone and mineral metabolism in PHPT. OBJECTIVE: The purpose of this study was to assess the effect of renal function on skeletal health in PHPT. DESIGN: This is a retrospective analysis of PHPT patients with (eGFR < 60 ml/min per 1.73 m(2)) and without chronic kidney disease (CKD) from our previously described PHPT cohort recruited from 1984 to 1991. SETTING: The study was conducted in a university hospital metabolic bone unit. PARTICIPANTS: One hundred thirty-eight women and men with PHPT were studied. OUTCOME MEASURES: We assessed bone mineral density (BMD) by dual-energy x-ray absorptiometry; quantitative histomorphometric indices from transiliac bone biopsies; and biochemical markers of mineral metabolism. RESULTS: Although there was no difference in serum or urinary calcium or PTH level, calcitriol levels were lower and phosphate levels higher in patients with CKD. BMD adjusted for weight did not differ at any site between groups. Histomorphometric analysis (n = 30 of 138) revealed a 45% greater eroded surface in those with CKD (P = 0.02). Eroded surface negatively correlated with eGFR (r = -0.46, P = 0.02) and phosphate (r = -0.48, P = 0.02) and positively correlated with serum calcium level (r = 0.51, P = 0.009) but not with PTH, alkaline phosphatase, vitamin D metabolites, or urinary calcium excretion. CONCLUSION: Although cardinal biochemical indices (such as calcium and PTH) and BMD do not differ in PHPT patients with an eGFR below 60 ml/min per 1.73 m(2), these patients have higher phosphate and histomorphometric evidence of altered bone remodeling compared with those without CKD.
CONTEXT: Current guidelines recommend parathyroidectomy in patients with primary hyperparathyroidism (PHPT) who have an estimated glomerular filtration rate (eGFR) less than 60 ml/min per 1.73 m(2). It is unclear, however, whether values below this threshold of renal impairment affect bone and mineral metabolism in PHPT. OBJECTIVE: The purpose of this study was to assess the effect of renal function on skeletal health in PHPT. DESIGN: This is a retrospective analysis of PHPT patients with (eGFR < 60 ml/min per 1.73 m(2)) and without chronic kidney disease (CKD) from our previously described PHPT cohort recruited from 1984 to 1991. SETTING: The study was conducted in a university hospital metabolic bone unit. PARTICIPANTS: One hundred thirty-eight women and men with PHPT were studied. OUTCOME MEASURES: We assessed bone mineral density (BMD) by dual-energy x-ray absorptiometry; quantitative histomorphometric indices from transiliac bone biopsies; and biochemical markers of mineral metabolism. RESULTS: Although there was no difference in serum or urinary calcium or PTH level, calcitriol levels were lower and phosphate levels higher in patients with CKD. BMD adjusted for weight did not differ at any site between groups. Histomorphometric analysis (n = 30 of 138) revealed a 45% greater eroded surface in those with CKD (P = 0.02). Eroded surface negatively correlated with eGFR (r = -0.46, P = 0.02) and phosphate (r = -0.48, P = 0.02) and positively correlated with serum calcium level (r = 0.51, P = 0.009) but not with PTH, alkaline phosphatase, vitamin D metabolites, or urinary calcium excretion. CONCLUSION: Although cardinal biochemical indices (such as calcium and PTH) and BMD do not differ in PHPT patients with an eGFR below 60 ml/min per 1.73 m(2), these patients have higher phosphate and histomorphometric evidence of altered bone remodeling compared with those without CKD.
Authors: A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker Journal: J Bone Miner Res Date: 1987-12 Impact factor: 6.741
Authors: M Parisien; F Cosman; R W Mellish; M Schnitzer; J Nieves; S J Silverberg; E Shane; D Kimmel; R R Recker; J P Bilezikian Journal: J Bone Miner Res Date: 1995-09 Impact factor: 6.741
Authors: N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey Journal: BMJ Date: 1995-02-11
Authors: M Parisien; R W Mellish; S J Silverberg; E Shane; R Lindsay; J P Bilezikian; D W Dempster Journal: J Bone Miner Res Date: 1992-08 Impact factor: 6.741
Authors: Daniel Cejka; Johann Herberth; Adam J Branscum; David W Fardo; Marie-Claude Monier-Faugere; Danielle Diarra; Martin Haas; Hartmut H Malluche Journal: Clin J Am Soc Nephrol Date: 2010-12-16 Impact factor: 10.614
Authors: C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola Journal: J Endocrinol Invest Date: 2015-03-28 Impact factor: 4.256
Authors: Marcella D Walker; Thomas Nickolas; Anna Kepley; James A Lee; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg Journal: J Clin Endocrinol Metab Date: 2014-02-14 Impact factor: 5.958
Authors: Jawed A Siddiqui; Joshua Johnson; Carole Le Henaff; Claudine L Bitel; Joseph A Tamasi; Nicola C Partridge Journal: Sci Rep Date: 2017-11-10 Impact factor: 4.379